Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Improving Translational Accuracy02:07

Improving Translational Accuracy

3.8K
3.8K
Improving Translational Accuracy02:07

Improving Translational Accuracy

15.7K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
15.7K
Translational Regulation01:29

Translational Regulation

890
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
890
Translation01:31

Translation

162.9K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
162.9K
Translation01:31

Translation

23.4K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
23.4K
Leaky Scanning02:28

Leaky Scanning

5.9K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Less frequent clinical and viral load assessments during COVID did not increase virological failure.

International journal of STD & AIDS·2026
Same author

Measuring Value in Orthopaedics: The U.S. and U.K. Perspectives.

The Journal of bone and joint surgery. American volume·2026
Same author

Don't Pay the Ferryman: International Aeromedical Transport of Patients to or From Treatments Prohibited in Their Place of Residence.

Air medical journal·2026
Same author

Switch to fixed-dose doravirine (100 mg) and islatravir (0·25 mg) once daily in virologically suppressed adults with HIV-1 on oral antiretroviral therapy: 48-week results of a phase 3, multicentre, randomised, open-label, non-inferiority trial.

Lancet (London, England)·2026
Same author

Translational Potential of an Electrospun Polycaprolactone Scaffold for Anterior Cruciate Ligament Reconstruction.

Advanced fiber materials·2026
Same author

Study protocol for a randomised controlled trial to determine the efficacy of lisdexamfetamine for the treatment of acute methamphetamine withdrawal in inpatient settings.

BMJ open·2025

Related Experiment Video

Updated: Apr 20, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.5K

Changing the mindset in life sciences toward translation: a consensus.

Georg N Duda1, David W Grainger2, Megan L Frisk3

  • 1Berlin-Brandenburg Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, Germany. Julius Wolff Institut, Charité-Universitätsmedizin Berlin, Germany. georg.duda@charite.de.

Science Translational Medicine
|November 28, 2014
PubMed
Summary

Experts identified the primary obstacle hindering progress in translational medicine. This consensus was reached at the Translate! 2014 meeting, focusing on accelerating the translation of research into clinical practice.

More Related Videos

Development of New Therapeutic Applications Using Microfluidics
08:56

Development of New Therapeutic Applications Using Microfluidics

Published on: October 1, 2007

5.7K
Quantitative Immunofluorescence to Measure Global Localized Translation
09:13

Quantitative Immunofluorescence to Measure Global Localized Translation

Published on: August 22, 2017

10.6K

Related Experiment Videos

Last Updated: Apr 20, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.5K
Development of New Therapeutic Applications Using Microfluidics
08:56

Development of New Therapeutic Applications Using Microfluidics

Published on: October 1, 2007

5.7K
Quantitative Immunofluorescence to Measure Global Localized Translation
09:13

Quantitative Immunofluorescence to Measure Global Localized Translation

Published on: August 22, 2017

10.6K

Area of Science:

  • Biomedical Research
  • Translational Medicine
  • Clinical Translation

Background:

  • Translational medicine aims to bridge the gap between laboratory discoveries and patient care.
  • Advancing translational medicine requires identifying and overcoming key bottlenecks.
  • The Translate! 2014 meeting convened experts to address these challenges.

Purpose of the Study:

  • To achieve a consensus on the most significant rate-limiting factor in translational medicine.
  • To guide future research and policy efforts in the field.

Main Methods:

  • Consensus-building among international experts at a dedicated scientific meeting.
  • Discussion and deliberation on the challenges facing translational research.

Main Results:

  • A key rate-limiting factor for advancing translational medicine was identified.
  • The consensus provides a focal point for addressing systemic issues.

Conclusions:

  • Addressing the identified rate-limiting factor is crucial for accelerating medical innovation.
  • The findings from Translate! 2014 offer strategic direction for the field.